Health topic

Breast Cancer

These are reviewed research connections, not a ranked list of remedies. An ingredient can appear here because evidence was uncertain, preclinical, or limited to a specific preparation and setting.

Ailment-to-evidence view

What the reviewed research points to

This order reflects the depth of the reviewed evidence, not which option works best or what anyone should take. Mixed and negative findings stay in the list because they can be more useful than a promising headline.

Early or contextual evidence Safety and tolerability only

Turkey Tail

The study provides early tolerability information but has no control group and is too small to evaluate cancer outcomes.

Studied form
Oral Trametes versicolor preparation at 3, 6, or 9 g/day for six weeks after radiation therapy
Outcome
Tolerability and exploratory immune measures
Evidence
Phase I, two-center, dose-escalation study without a control group
See the evidence and cautions →
How this order is calculated

Evidence syntheses come before individual randomized trials, which come before early human and preclinical work. Sample-size bands add a small amount. Positive, mixed, negative, and safety-only directions do not change the depth score. Study independence is not yet scored, so overlapping reviews must not be counted as separate confirmation.

Connected ingredients

What appears in the current evidence map

Source-linked records

1 reviewed record

Early human study Safety and tolerability only 11 recruited, 9 completed

Turkey Tail preparation after breast cancer treatment: phase I study

Nine women completed this early dose-escalation study. It was designed mainly to examine tolerability and immune measures, not whether Turkey Tail prevents recurrence or improves survival.

What was studied
Oral Trametes versicolor preparation at 3, 6, or 9 g/day for six weeks after radiation therapy
Setting
Not an efficacy study
Why it ranks here
The study provides early tolerability information but has no control group and is too small to evaluate cancer outcomes.
Limits and cautions
  • Only nine participants completed the study.
  • There was no placebo or untreated comparison group.
  • Immune changes are not proof of improved cancer outcomes.

Turkey Tail products are not FDA-approved in the United States as a cancer treatment.